Page last updated: 2024-11-04

vorinostat and Leukemia, Large Granular Lymphocytic

vorinostat has been researched along with Leukemia, Large Granular Lymphocytic in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Leukemia, Large Granular Lymphocytic: A spectrum of disorders characterized by clonal expansions of the peripheral blood LYMPHOCYTE populations known as large granular lymphocytes which contain abundant cytoplasm and azurophilic granules. Subtypes develop from either CD3-negative NATURAL KILLER CELLS or CD3-positive T-CELLS. The clinical course of both subtypes can vary from spontaneous regression to progressive, malignant disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, X1
Hasanali, ZS1
Chen, A1
Zhang, D1
Liu, X1
Wang, HG1
Feith, DJ1
Loughran, TP1
Xu, K1

Other Studies

1 other study available for vorinostat and Leukemia, Large Granular Lymphocytic

ArticleYear
Suberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia.
    British journal of haematology, 2015, Volume: 168, Issue:3

    Topics: Acetylation; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cladribine; Dose-Response Re

2015